Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1991 1
1992 1
1993 2
1994 2
1995 2
1996 5
1997 3
2000 6
2001 3
2002 6
2003 7
2004 6
2005 11
2006 11
2007 12
2008 17
2009 17
2010 23
2011 29
2012 20
2013 27
2014 23
2015 32
2016 31
2017 23
2018 20
2019 29
2020 40
2021 31
2022 31
2023 29
2024 30
2025 34

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

495 results

Results by year

Filters applied: . Clear all
Page 1
Child and adolescent obesity.
Lister NB, Baur LA, Felix JF, Hill AJ, Marcus C, Reinehr T, Summerbell C, Wabitsch M. Lister NB, et al. Nat Rev Dis Primers. 2023 May 18;9(1):24. doi: 10.1038/s41572-023-00435-4. Nat Rev Dis Primers. 2023. PMID: 37202378 Review.
Targeting PI3K/AKT signaling pathway in obesity.
Savova MS, Mihaylova LV, Tews D, Wabitsch M, Georgiev MI. Savova MS, et al. Biomed Pharmacother. 2023 Mar;159:114244. doi: 10.1016/j.biopha.2023.114244. Epub 2023 Jan 11. Biomed Pharmacother. 2023. PMID: 36638594 Free article. Review.
Factors affecting early-life intestinal microbiota development.
Vandenplas Y, Carnielli VP, Ksiazyk J, Luna MS, Migacheva N, Mosselmans JM, Picaud JC, Possner M, Singhal A, Wabitsch M. Vandenplas Y, et al. Nutrition. 2020 Oct;78:110812. doi: 10.1016/j.nut.2020.110812. Epub 2020 Mar 25. Nutrition. 2020. PMID: 32464473 Review.
Hypothalamic obesity: from basic mechanisms to clinical perspectives.
Argente J, Farooqi IS, Chowen JA, Kühnen P, López M, Morselli E, Gan HW, Spoudeas HA, Wabitsch M, Tena-Sempere M. Argente J, et al. Lancet Diabetes Endocrinol. 2025 Jan;13(1):57-68. doi: 10.1016/S2213-8587(24)00283-3. Epub 2024 Nov 12. Lancet Diabetes Endocrinol. 2025. PMID: 39547253 Review.
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T. Brown RJ, et al. J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6. J Clin Endocrinol Metab. 2016. PMID: 27710244 Free PMC article. Review.
Kurzzeitige Behandlung von Patient_innen mit Anorexia nervosa mit rekombinant hergestelltem Human-Leptin (Metreleptin): Rasch einsetzende positive Effekte auf Stimmung, Kognition und Verhalten.
Hebebrand J, Antel J, Tan S, Wabitsch M, Wiesing U, Barth N, Ludwig C, Bühlmeier J, Libuda L, Milos G, Hinney A. Hebebrand J, et al. Z Kinder Jugendpsychiatr Psychother. 2021 Jan;49(1):1-5. doi: 10.1024/1422-4917/a000775. Z Kinder Jugendpsychiatr Psychother. 2021. PMID: 33423560 Free article. German. No abstract available.
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators. Clément K, et al. Lancet Diabetes Endocrinol. 2020 Dec;8(12):960-970. doi: 10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30. Lancet Diabetes Endocrinol. 2020. PMID: 33137293 Clinical Trial.
495 results